Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Prasad Mathew, MD
University of New Mexico Cancer Center
Study Chair - Robert J. Arceci, MD, PhD
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
85 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Princess Margaret Hospital for Children
Perth, Western Australia, Australia
- University of Alberta Hospital
Edmonton, Alberta, Canada
- Children'S & Women'S Hospital of British Columbia
Vancouver, British Columbia, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Iwk Health Centre
Halifax, Nova Scotia, Canada
- Mcmaster Children'S Hospital at Hamilton Health Sciences
Hamilton, Ontario, Canada
- Cancer Centre of Southeastern Ontario at Kingston General Hospital
Kingston, Ontario, Canada
- Hopital Sainte Justine
Montreal, Quebec, Canada
- Montreal Children'S Hospital at Mcgill University Health Center
Montreal, Quebec, Canada
- Centre Hospitalier Universitaire de Quebec
Québec, Canada
- San Jorge Children'S Hospital
Santurce, Puerto Rico
- Phoenix Children'S Hospital
Phoenix, Arizona, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Jonathan Jaques Children'S Cancer Center at Miller Children'S Hospital
Long Beach, California, United States
- Children'S Hospital Central California
Madera, California, United States
- Kaiser Permanente Medical Center - Oakland
Sacramento, California, United States
- Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center
Farmington, Connecticut, United States
- Lee Cancer Care of Lee Memorial Health System
Fort Myers, Florida, United States
- University of Florida Shands Cancer Center
Gainesville, Florida, United States
- Memorial Cancer Institute at Memorial Regional Hospital
Hollywood, Florida, United States
- Miami Children'S Hospital
Miami, Florida, United States
- Sacred Heart Cancer Center at Sacred Heart Hospital
Pensacola, Florida, United States
- All Children'S Hospital
St. Petersburg, Florida, United States
- St. Joseph'S Cancer Institute at St. Joseph'S Hospital
Tampa, Florida, United States
- Kaplan Cancer Center at St. Mary'S Medical Center
West Palm Beach, Florida, United States
- Winship Cancer Institute of Emory University
Atlanta, Georgia, United States
- Cancer Research Center of Hawaii
Honolulu, Hawaii, United States
- Advocate Christ Medical Center
Oak Lawn, Illinois, United States
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- St. Vincent Indianapolis Hospital
Indianapolis, Indiana, United States
- Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas, United States
- Kosair Children'S Hospital
Louisville, Kentucky, United States
- Ochsner Cancer Institute at Ochsner Clinic Foundation
New Orleans, Louisiana, United States
- Cancercare of Maine at Eastern Maine Medial Center
Bangor, Maine, United States
- Alvin and Lois Lapidus Cancer Institute at Sinai Hospital
Baltimore, Maryland, United States
- Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
- Hurley Medical Center
Flint, Michigan, United States
- Spectrum Health Hospital - Butterworth Campus
Grand Rapids, Michigan, United States
- Van Elslander Cancer Center at St. John Hospital and Medical Center
Grosse Pointe Woods, Michigan, United States
- Breslin Cancer Center at Ingham Regional Medical Center
Lansing, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2005
- Primary completion
- 31 Oct 2007
- Completion
- 31 Oct 2009
- Last update posted
- 13 Feb 2014
- Registered enrollment
- 10
- Registry id
- NCT00098683
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.